Advanced Thyroid Carcinoma clinical trials

Explore recruiting advanced thyroid carcinoma clinical trials.

Recruiting advanced thyroid carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Thyroid Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prospective, multicenter, randomized study on combined LT4 + LT3 therapy versus LT4 in the control of TSH in patients with advanced thyroid cancer treated with tyrosine kinase inhibitors.

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Advanced Thyroid Carcinoma trials by city

Advanced Thyroid Carcinoma clinical trials

Recruiting advanced thyroid carcinoma studies right now

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

Agnostic Therapy in Rare Solid Tumors

HEC169096 in Participants With Advanced Solid Tumors

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer

Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery

Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer

Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer

Also recruiting in Europe

Prospective, multicenter, randomized study on combined LT4 + LT3 therapy versus LT4 in the control of TSH in patients with advanced thyroid cancer treated with tyrosine kinase inhibitors.

Advanced Thyroid Carcinoma trials by city

Other conditions